03.09.2021 - By Psychopharmacology Institute
Are long-acting injectable antipsychotics better than oral antipsychotics for preventing relapse and re-hospitalization in schizophrenia? Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about Premium Membership here Earn 0.5 CME: Quick Take Vol. 17 Long-Acting Injections in Schizophrenia: A 3-Year Update on Randomized Controlled Trials Published January 2016–March 2019